Makers of Bayer Aspirin Announce Support of National Women's Heart Health Organization Through Educational Grant
MORRISTOWN, N.J., Feb. 9 /PRNewswire/ -- Bayer HealthCare LLC, the makers of Bayer(R) Aspirin, announced today their support of WomenHeart, the nation's only education and advocacy organization solely dedicated to promoting women's heart health, with a $100,000 educational grant from the Bayer USA Foundation.
An estimated 44 million American women live with or are at risk of heart disease, but too many are unaware of the threat they face. In fact, heart disease is the #1 killer of American women with nearly one-third (27.2 percent) of all female deaths each year from heart disease. Of the 500,000 annual deaths from cardiovascular disease, 267,000 women die from heart attacks -- six times more than will die from breast cancer.
Additionally, heart disease is more likely to be treated and prevented accurately in men than women. A study published in the May 2008 issue of the journal Heart showed that among heart patients, women were less likely than men to receive beta blockers, statins and ACE inhibitors -- medications critical in the treatment of heart disease. Women are also less likely to receive ICDs (an implanted device that helps to control irregular heartbeats) and therapies such as physician-recommended aspirin, which if taken can help prevent certain cardiovascular events.
"The Bayer USA Foundation and Bayer Consumer Care are pleased to support WomenHeart and the organization's mission to improve the health and quality of the lives of women living with or at risk of heart disease," said Bayer Aspirin Brand Director Rob Schumm. "Its activities align with Bayer's own cardiovascular public health objectives of increasing the awareness of prevention and early detection, accurate diagnosis and proper treatment of heart disease."
Through the grant, WomenHea
|SOURCE Bayer HealthCare LLC|
Copyright©2009 PR Newswire.
All rights reserved